Victoria Maniatis leads Sanders Phillips Grossman’s Taxotere Alopecia litigation team. She is passionate about women’s health issues and has many years of experience in mass tort litigation, concentrating specifically on pharmaceutical and medical device claims.
Both federal and state judges have appointed Ms. Maniatis as lead counsel on various Plaintiffs’ steering committees, including Fosamax Femur Fracture litigation as well as the Bard, Boston Scientific, Ethicon, and American Medical Systems cases within the Transvaginal Mesh litigation. She is lead counsel in New Jersey’s Propecia Multi-County Litigation.
She is one of the founding members of the Mass Tort Medical School’s annual medical seminar for Plaintiffs’ attorneys and committee co-chair for the Women en Masse mass tort group.
Ms. Maniatis is also an avid triathlete and has one son.
Read more about Sanders Phillips Grossman attorneys here.
ABOUT SANDERS PHILLIPS GROSSMAN
Sanders Phillips Grossman has been holding pharmaceutical companies responsible for injuring individuals by their defective drugs and devices for over 30 years. Defective drugs are pharmaceuticals with side effects that potentially harm, injure, or kill the patient to the point that they outweigh the drug’s intended benefits. Defective devices, such as faulty prosthetics, implants, pacemakers, or surgical instruments can harm patients when the product is defective in the manufacturing process, design, or marketing strategy.
Pharmaceutical companies are some of the largest, wealthiest, and most influential corporate entities in the world. Sanders Phillips Grossman and its predecessors have recovered over one billion dollars for injured consumers. Our firm’s history in dealing with drug and medical device injury claims has allowed us to take leadership roles in many of the national defective drug and device litigations.
Nationally recognized as a leading plaintiff’s law firm, we handle cases in all 50 states and Puerto Rico.
Read more about our attorneys here.